When did Bwx Technologies Inc file this 8-K?

Bwx Technologies Inc (BWXT) filed this Current Report (Form 8-K) with the SEC on May 5, 2026. The accession number assigned by EDGAR is 0001486957-26-000031.

What does an 8-K disclose?

Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).

What is the key takeaway from this filing?

Ten directors elected for 1-year terms; advisory approval of 2025 executive compensation; Deloitte ratified as auditor. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.

What Item codes does an 8-K cover?

An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.

Where can I find Bwx Technologies Inc's prior current reports on EDGAR?

The SEC EDGAR browser lists every 8-K Bwx Technologies Inc has filed under CIK 1486957, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.

Boardroom Alpha

BWXT · Current Report (Form 8-K) · Filed May 5, 2026

Bwx Technologies Inc — Current Report (Form 8-K)

Form

8-K

Filed

May 5, 2026

Period

Apr 30, 2026

Ticker

BWXT

Accession

0001486957-26-000031

Bwx Technologies Inc on Boardroom Alpha View on SEC EDGAR

Boardroom Alpha · Filing insights

Ten directors elected for 1-year terms; advisory approval of 2025 executive compensation; Deloitte ratified as auditor.

About Bwx Technologies Inc

Market cap

$14.3B

1Y TSR

−2.1%

3Y TSR

+32.3%

Board grade

B-

Sector

Industrials

CEO

Rex D Geveden

Last annual meeting: Apr 30, 2026 · View full Bwx Technologies Inc profile →

bwxt-20260430

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________________________________________________________

FORM 8-K

______________________________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 30, 2026

BWX TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

_____________________________________________________________________________

Delaware

001-34658

80-0558025

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

800 Main Street, 4th Floor

Lynchburg,

Virginia

24504

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (980) 365-4300

____________________________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	BWXT	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company			☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting on April 30, 2026, the Company's stockholders voted on three matters. A brief description of, and the final vote result for, each matter voted on at the Annual Meeting are set forth below. Each matter is described in more detail in our Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on March 18, 2026.

Proposal 1: Election of ten directors to serve a one-year term expiring at the 2027 annual meeting of stockholders and until their successors are duly elected and qualified:


Nominee	Votes For	Votes Against	Abstentions	Broker Non-Votes
Jan A. Bertsch	74,212,190	902,977	139,832	6,688,652
Gerhard F. Burbach	74,476,706	639,302	138,991	6,688,652
Rex D. Geveden	74,905,919	287,195	61,885	6,688,652
Daniel L. Jablonsky	75,011,709	103,844	139,446	6,688,652
James M. Jaska	74,567,324	556,878	130,797	6,688,652
Kenneth J. Krieg	74,221,695	902,329	130,975	6,688,652
Leland D. Melvin	74,696,227	483,046	75,726	6,688,652
Barbara A. Niland	74,268,572	840,840	145,587	6,688,652
Nicole W. Piasecki	68,316,115	6,797,898	140,986	6,688,652
John M. Richardson	74,615,088	504,354	135,557	6,688,652

Proposal 2: Advisory vote to approve the 2025 compensation of our named executive officers:


Votes For	Votes Against	Abstentions	Broker Non-Votes
73,952,557	1,110,500	191,942	6,688,652

Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026:


Votes For	Votes Against	Abstentions
81,613,342	265,947	64,362

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			BWX TECHNOLOGIES, INC.

			By:						/s/ Toby W. Smith
									Toby W. Smith
									Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

May 5, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

See Filings Intelligence Schedule a Demo

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bwx Technologies Inc (BWXT)

10-Q/AAmended Quarterly Report
Aug 5, 2026
10-QQuarterly Report
Aug 3, 2026
8-KCurrent Report
Aug 3, 2026
10-QQuarterly Report
May 4, 2026
8-KCurrent Report
May 4, 2026
DEFA14AAdditional Proxy Materials
Mar 18, 2026
DEF 14AProxy Statement
Mar 18, 2026
10-KAnnual Report
Feb 23, 2026
8-KCurrent Report
Feb 23, 2026
8-KCurrent Report
Feb 20, 2026
8-KCurrent Report
Nov 10, 2025
8-KCurrent Report
Nov 5, 2025

Continue researching

Reference

Frequently asked questions

When did Bwx Technologies Inc file this 8-K?: Bwx Technologies Inc (BWXT) filed this Current Report (Form 8-K) with the SEC on May 5, 2026. The accession number assigned by EDGAR is 0001486957-26-000031.
What does an 8-K disclose?: Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?: Ten directors elected for 1-year terms; advisory approval of 2025 executive compensation; Deloitte ratified as auditor. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?: An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Bwx Technologies Inc's prior current reports on EDGAR?: The SEC EDGAR browser lists every 8-K Bwx Technologies Inc has filed under CIK 1486957, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer